Sign in
0RA9 Stock Price, Chart, Stats & News
Abivax S.A.
Save
Abivax S.A. (0RA9) does not currently pay a dividend.
8.17B
Market cap
–
Current P/E
–
Forward P/E
0RA9 chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
Based in Paris, France, ABIVAX Société Anonyme is a biopharmaceutical company dedicated to the discovery and optimization of novel drug treatments. Their research and development efforts primarily target inflammatory conditions, infectious diseases, and various forms of cancer. A central asset in their pipeline is ABX464, which is currently undergoing Phase IIb clinical trials for ulcerative colitis and Crohn's Disease, and is also being investigated for COVID-19.
Similar securities
Based on sector and market capitalization
Report issue